# Takayasu Arteritis Clinical Trial in China

> **NCT02981979** · NA · COMPLETED · sponsor: **Jiang lindi** · enrollment: 116 (actual)

## Conditions studied

- Takayasu Arteritis

## Interventions

- **DRUG:** Leflunomide(LEF)
- **DRUG:** Prednisone Acetate Tablets
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02981979
- **Lead sponsor:** Jiang lindi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-22
- **Primary completion:** 2022-05-22
- **Final completion:** 2022-11-22
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981979, "Takayasu Arteritis Clinical Trial in China". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT02981979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*